Cargando…
A Review of the Use of Biological Agents in Human Immunodeficiency Virus Positive Patients With Rheumatological Diseases
After approval, initial biologics etanercept, infliximab, and adalimumab became useful in the therapeutic armamentarium to treat rheumatoid arthritis (RA) patients who had an inadequate response to disease-modifying anti-rheumatic drugs (DMARDs). However, all phase-III clinical trials submitted to t...
Autores principales: | Attallah, Marline A, Jarrin Jara, Maria Daniela, Gautam, Avneesh S, Peesapati, Venkata Sri Ramani, Khan, Safeera |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667623/ https://www.ncbi.nlm.nih.gov/pubmed/33209528 http://dx.doi.org/10.7759/cureus.10970 |
Ejemplares similares
-
The Role of Interleukin-6 and Inflammatory Cytokines in Pancreatic Cancer-Associated Depression
por: Jarrin Jara, Maria Daniela, et al.
Publicado: (2020) -
Panoramic Dominance of the Immune System in Cardiorenal Syndrome Type I
por: Peesapati, Venkata Sri Ramani, et al.
Publicado: (2020) -
Angiodysplasia in Renal Disease Patients: Analysis of Risk Factors and Approach to Manage Such Patients
por: Verma, Sadhika, et al.
Publicado: (2020) -
A Comparative Analysis of Microscopy, Culture, and the Xpert Mycobacterium tuberculosis/Rifampicin Assay in Diagnosing Pulmonary Tuberculosis in Human Immunodeficiency-Positive Individuals
por: Kumar, Manish, et al.
Publicado: (2023) -
Human Immunodeficiency Virus in Adults Undergoing Surgery for Brain Tumors
por: Harris, Lauren, et al.
Publicado: (2022)